Search for a command to run...
No change in Promoter and Institution holdings suggests a lack of confidence in Indo US Bio-Tech Ltd. among smart money.
Public shareholding has slightly increased year-on-year but decreased quarter-on-quarter, indicating potential retail fatigue.
The stock does not show resilience compared to sector peers like NARMADA, which saw significant institutional buying.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter5 | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | 70.17% | |
2Institution | - | - | - | - | - | - | - | - | |
3Public8 | 9.77% | 6.73% | 6.73% | 6.83% | 6.78% | 6.77% | 6.77% | 7.36% |